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ABSTRACT
Background and Objective: Infantile spasm (IS) is one of the severe epileptic encephalopathies which
affect children in early two years of life. Our objective was to determine the clinical profile, etiology
and outcome of treatment in children with infantile spasms attending tertiary care hospital at Karachi,
Pakistan.
Methods: This is retrospective study of 36 patients out of 94 registered as IS, aged three months to two
years, managed and followed up at Aga Khan University Hospital, Karachi, from 2010 to 2015. Data of all
children with IS was collected from case record. Details including clinical observations, lab investigations,
anti-epileptic medications and treatment outcome was collected and analyzed. Patients who received
treatment for six weeks to document response were included. The treatment response was categorized
as complete response, partial response (>50% improvement) and no response. Data was analyzed on SPSS
using descriptive statistics.
Results: Thirty-six patients (38.29%) with IS fulfilled eligibility criteria. The mean ± SD age at presentation
was 4.6±2.1 months. Male to female ratio was 2:1. Consanguinity and developmental motor delay was
observed in 66.6% and 89% respectively. Symptomatic etiology was predominant (61%) and hypoxic ischemic
insult (32%) was the commonest underlying cause. EEG and MRI were diagnostic tools whereas metabolic
studies were not helpful. Multiple antiepileptic drugs were used for seizure control and vigabatrin was
the most frequently used (88%) drug. Short term treatment response was not different in idiopathic or
symptomatic infantile spasms.
Conclusion: Majority of patients had symptomatic infantile spasms and generalized tonic clonic along with
myoclonic jerks were predominant seizure types. EEG and MRI were diagnostic in most of cases. Multiple
AEDs were required to control seizures and VGB was most common drug (88%) used. Treatment outcome
was not different in idiopathic and symptomatic groups.
KEYWORDS: Epileptic Encephalopathies, Electroencephalographic, Hypsarrythmia, Myoclonic jerks,
Vigabatrin.
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Infantile spasm (IS) is a distinctive disorder,
which affects the individual during infancy and
early childhood.1,2 It is one of the severe epilepsies
of childhood and is indicative of a true Epileptic
Encephalopathy.3 The incidence of infantile spasms
is one per 2000-6000 live births.4,5 Infantile spasms
usually develops before 12 months of age, with
only 8% of cases occurring in children above one
year of age.6
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It is characterized by abrupt, symmetric flexion
and/or extension of the neck, trunk and extremities.
IS is diagnosed by typical electroencephalographic
(EEG) findings of hypsarrythmia.7 Infantile spasms
have been classified as symptomatic when etiology
is known and cryptogenic/idiopathic when no
known cause is found. Majority (60-80%) of the
cases represent symptomatic group.8
The type of convulsion in IS depends on which
muscle groups (flexor or extensor) are primarily
affected and on the extent of the contraction. Flexor
spasms have long been considered as the most
characteristic type of seizure constituting 42% of the
cases while mixed flexor extensor spasms form 50%
of all cases.9
The etiology is highly varied and includes
neurocutaneous syndromes, metabolic disorders,
cortical malformations, perinatal brain injuries,
postnatal infections and head trauma. Commonly,
infantile spasms are associated with hypoxicischemic insult, tuberous sclerosis and cortical
malformations.10 Children may present with
infantile spasms alone or in combinations of West
syndrome. West syndrome is characterized by
cognitive deterioration along with infantile spasms
and hypsarrhythmia or modified hypsarrhythmia
on EEG.11
Children with IS require extensive evaluation
to identify the etiology and an EEG is essential to
confirm the diagnosis of infantile spasm. Magnetic
Resonance Imaging (MRI), metabolic workup and
more recently genetic analysis may be required.12
Management of infantile spasm is challenging
one since standard anticonvulsant drugs (AEDs)
are not effective. Long term outcome is not well
established and the children with IS often has a
poor outcome. Disagreement regarding optimal
treatment and long-term outcome exists due to
variation in classification, treatment strategies
and lack of evidence-based cost-effective AEDs.
The outcome of IS based on etiology is different in
symptomatic and cryptogenic /idiopathic group.13
Management of patients in resource-limited
settings is constrained by delay in diagnosis and high
cost of remedies.14 Though information exists on
various aspects of childhood seizure disorders, but
there is little information in the literature regarding
infantile spasms in developing countries specially
Pakistan.2 Henceforth, this retrospective study was
conducted to evaluate the clinical spectrum and
treatment outcome of children with infantile spasms
at tertiary care center in a developing country.
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METHODS
This study was conducted at the Department
of Pediatrics and Child Health, the Aga Khan
University Hospital, a private sector tertiary care
teaching hospital in Karachi, Pakistan. The study
protocol was approved by Institutional Ethics
Committee (4147-Ped-ERC-17). Data were collected
by retrospective chart review of all patients
diagnosed as Infantile Spasms from January 2010
to December 2015. Cases were identified by using
hospital information management system and
international classification of disease-10 (ICD-10)
coding G40.82 for infantile spasms.
Patients were evaluated with detailed history,
physical examination and pertinent investigations
were carried out. Patients were diagnosed as IS when
they presented with characteristic epileptic spasms
and hypsarrhythmia or modified hypsarrythmia
was found on EEG.
Further workup like MRI was done for
associated risk factors (eg perinatal insult) or
etiological factors (neurocutaneous syndrome,
inborn errors of metabolism). Children with
consanguineous parents, history of sibling deaths
and developmentally delay in family members
underwent metabolic workup like plasma
ammonia, lactate, amino acids and urine for organic
acids. Comorbid conditions like visual problems,
hearing impairment and recurrent chest infection
were assessed and recorded.
Based on the etiology, IS was classified as
symptomatic (known etiology) or cryptogenic/
idiopathic (unknown etiology). Patients were treated
initially with standard AEDs (e.g. phenobarbitone,
valproic acid) and subsequently according to
need, placed on specific drugs like oral vigabatrin
(VGB), prednisolone and parenteral adrenocortical
hormone (ACTH) or methylprednisolone. Outcome
of the treatment was assessed at six weeks and
categorized as complete response when no seizures
observed after six weeks, partial response if more
than 50% decrease in spasms and no response if
patient remain symptomatic.
Children aged less than three months, aged
more than two years and with follow -up for less
than 12 months were excluded. The data collected
on proforma included gender, age of onset of
infantile spasms, age at diagnosis and initiation
of treatment, type of spasms (flexor, extensor and
others), etiological factors (perinatal events, mode
of delivery, developmental delay, neurocutaneous
syndromes), MRI and EEG findings as well type of
treatment and response.
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The data was analyzed by SPSS version 19 using
descriptive statistics. Categorical variables like
gender and response to treatment were expressed
as frequency and percentages while continuous
variables like age were expressed as mean+/- SD.
Chi square test was used to see the association of
etiology with treatment response and P value of
<0.05 was taken as significant.
RESULTS
A total of 94 patients with IS were registered
during study period and 36 (38.29%) fulfilled
the eligibility criteria. Clinical profile of study
population is shown in Table-I. Boys were
predominant (66. 6%). The mean ± SD age of onset
of symptoms, diagnosis and initiation of treatment
was 4.6± 2.1 and 6.5± 3.6. months respectively.
Lag time from onset of symptom and diagnosis
in our study was two months. Consanguinity and
developmental motor delay were observed in 66.6%
and 89% respectively. The most common type of
epileptic spasm was generalized tonic clonic along
with myoclonic jerks (38.7%) followed by flexor
spasms (30.5%) and mixed type (28%).
Table-I: Clinical profile of patients
with infantile spasms (N=36).
Variable

Values

Gender

Male 24 (66.6%)
Female 12 (33.33%)

Cnsanguinity
Microcephaly
Developmental delay
Mode of delivery
LSCS
SVD
Age (months) ± SD
At onset of spasm
At diagnosis of spasm
At initiation of treatment
Type of spasms
Flexor
Extensor
Mixed
Generalized tonic clonic
along with myoclonus
Comorbidities
Visual impairment
Hearing impairment
Recurrent chest infections
More than two comorbidities
None
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26 (72%)
24 (66.6%)
32 (89%)
23 (64%)
13(36%
4.6 ± 2.0
6.5± 3.5
6.5 ± 3.5
11 (30.5%)
01 (2.8%)
10 (28%)
14 (38.7%)

6 (16.7%)
2 (5.6%)
7 (19.5%)
13 (36%)
8(22.2%)
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Table-II: Etiological Profile of children with
Symptomatic Infantile Spasms (N=22).
Etiology

N (%)

Hypoxic ischemic encephalopathy

7 (32)

Post-meningitic sequalae

3 (13.6)

Congenital brain malformation

3 (13.6)

Perinatal stroke

3 (13.6)

Hypoglycemia

2 (9)

Inborn errors of metabolism

2 (9)

Tuberous sclerosis

1 (4.6)

Prematurity

1 (4.6)

Forty two percent had weight below 5th percentile
and 61% were micro cephalic. Based on etiological
classification (Table-II), symptomatic IS was the
most common type (61%). The most common
cause among the symptomatic infantile spasms
was hypoxic ischemic insult (32%), followed by
post meningitic sequelae (13.6%) and perinatal
stroke (13.6%). Two children had IEM and one had
tuberous sclerosis.
The diagnostic workup in children with IS is
shown in Table-III. Hypsarrhythmia (69%) was the
most common EEG finding followed by modified
hypsarrhythmia (31%). Fifty two percent of our
patients underwent repeat EEG after six weeks of
therapy and it was normal in 32% patients.
Table-III: Diagnostic profile of children
with infantile spasm (N=36).
Electrophysiological studies

N (%)

Hypsarrhythmia
Modified hypsarrhythmia

25 (69)
11(31)

Magnetic Resonance Imaging findings

N= 36

Normal
Abnormal MRI findings
Ischemia/hemorrhage
Congenital brain malformation
Brain atrophy
Cortical tubers
Brain tumor

23 (64)
13 (36)
6 (46)
3 (23)
2 (15.6)
1 (7.7)
1 (7.67)

Metabolic workup

25 (70%)

Biotinidase deficiency
Elevated VLCFA

1 (4)
1 (4)

VLCFA= Very long chain fatty acids.
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Table-IV: Therapeutic response in
children with infantile spasms (N=36).
Response to treatment

Symptomatic
group
N=22(61%)

Idiopathic
group
N=14(39%)

Complete response *

6 (27.2)

4 (28.6)

Partial response *

11 (50)

9(64.3)

No response

5 (22.8)

1(7.1)

* P-value =0.41
MRI was carried out in all patients; it was
normal in 64% and abnormal in 36%. Most
common radiological findings were vascular
events (ischemia/hemorrhage in 46%) followed by
congenital brain malformations (23%). Metabolic
work up was carried out in 25 children (70%) and
it showed biotinidase deficiency and elevated very
long chain fatty acids each in one case. All children
received multiple AEDs and 52% of cases required
more than four AEDs to control the seizure. VGB
was used in 88% of the children while ACTH was
given to 50%.
Use of VGB preceded ACTH except for two
children in whom ACTH was used without VGB,
because one was already on ACTH replacement
therapy for panhypopituitarism and in other VGB
was contraindicated.
Considering the treatment response (Table-IV),
complete response was almost similar in both groups
(symptomatic 27% vs cryptogenic 28%) whereas partial response (50% vs 64%) and no response (22.8%
vs 7.1%) were different in cryptogenic/ idiopathic
and symptomatic group but it was not significant
(p-value 0.41). Hypertension was observed in 50%
of children who received ACTH whereas only one
developed cushingoid appearance.
DISCUSSION
This study highlights the clinical profile and
outcome of children with infantile spasm at a
tertiary care center with well-established pediatric
neurology subspecialty. We observed a male
preponderance which is similar to other studies
from India, Sweden and South Africa.15,16
The mean age of onset of infantile spasms in our
study (4.6 months) is comparable to a study by
Kaushik JS et al. in which it was 5.3 months.15 Mean
lag time in our study (2 months) is less than reported
by Kaushik JS et al.15 However, it is much less in
developed countries (25- 45 days).13,17 This may
reflect lack of awareness of this condition in parents,
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family physicians and general pediatricians.18
Furthermore, this paucity of knowledge may have
resulted in delay in diagnosis, inappropriate choice
and dosage of AEDs.19,20
In the current study, we found symptomatic
epileptic spasms in 61% which is similar to
our previous study from same center (64.3%).
Among the symptomatic group, perinatal events
constituted 32% which has significantly decreased
from previous figures (70%).21 This may be due to
improvement in availability and better obstetric
care.22 A similar recent study, published from South
Africa by Keshave et al showed that perinatal events
accounted for 50% of the symptomatic cases.23
The most common type of epileptic spasm in our
study was flexor spasms (30.5%) which is less than
76% reported by Kaushik JS et al.15 Mixed type of
spasms (28%) in our study is more than reported by
Kaushik JS et al. We found hypsarrythmia pattern in
EEG, the most common occurrence (69%) followed
by modified hypsarrythmia (31%) which is well
established findings in many studies.15,22-24 Keshave
et al. reported hypsarrythmia in 62% of patients in
his study.23
The primary goal of management in infantile
spasms is seizure control and improved long term
developmental outcome. Though we did not find
difference in treatment response in symptomatic
versus idiopathic IS groups, but overall response
was better in cryptogenic/idiopathic (92.9%)
compared to symptomatic spasms (77.2%). Similar
treatment response has been reported in other
studies.1,22,23,25
Strengths and Limitations: The study on clinical
profile and treatment outcome of children with
IS over a period of 5 years with complete follow
up highlights the pediatric neurology practice.
However, we acknowledge our limitation of a small
sample size from a single center in which we have
not considered detailed response to individual
AEDs.
CONCLUSION
In our study symptomatic infantile spasms
were predominant and were associated with
consanguinity (66.6%), developmental delay
(89%) and microcephaly. Generalized tonic-clonic
seizure along with myoclonic jerks (38.7%), flexor
spasms (30.5%) and in combination (28%) were
type of seizures. Hypoxic ischemic insult (32%) was
important cause of symptomatic infantile spasms.
EEG was diagnostic in most of cases; MRI was useful
in detecting vascular events and brain malformations
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whereas metabolic workup was not helpful. Multiple
AEDs were required to control seizures and VGB
was most common drug (88%) used. Short term
treatment response was not different in idiopathic or
symptomatic infantile spasms.
This may help pediatricians in identifying types
of infantile spasms, guiding diagnostic workup and
treatment outcome. Studies with larger sample size
and prospective in nature to determine the outcome
are suggested.
Grand Support and Financial Disclosure: None.
REFERENCES
1.

2.
3.
4.

5.

6.
7.

8.
9.
10.
11.
12.
13.

14.
15.

Lagae L, Verhelst H, Ceulemans B, De Meirleir L, Nassogne
M-C, De Borchgrave V, et al. Treatment and long term
outcome in West syndrome: The clinical reality. A
multicentre follow up study. Seizure. 2010;19(3):159-164.
doi: 10.1016/j.seizure.2010.01.008.
Malik MA, Tarrar MA, Qureshi AO, Rehman MZ. Clinical
Spectrum of Infantile Spasm at Presentation. J Coll
Physicians Surg Pak. 2012;22(1):31-34.
Yu J, Pearl P. Metabolic causes of epileptic encephalopathy.
Epilepsy Res Treat. 2013;124934. doi: 10.1155/2013/124934.
Salomon JA, Vos T, Hogan DR, Gagnon M, Naghavi M,
Mokdad A, et al. Common values in assessing health outcomes
from disease & injury: Disability weights measurement study
for the Global Burden of Disease Study 2010. Lancet. 2012;
380:2129-2143. doi: 10.1016/S0140-6736(12)61680-8.
Thurman DJ, Beghi E, Begley CE, Berg AT, Buchhalter
JR, Ding D, et al. Standards for epidemiologic studies
and surveillance of epilepsy. Epilepsia. 2011;52(7):2-26.
doi: 10.1111/j.1528-1167.2011.03121. x.
Taghdiri MM, Nemati H. Infantile spasm: A review article.
Iran J Child Neurol. 2014;8(3):1.
Kendall Nash and Joseph Sullivan. Myoclonic seizures
and infantile spasms. In Swaiman KF, Ashwal S, Ferriero
DM, Schor NF editors. Swaiman’s pediatric Neurology:
Principles and Practice. 5th ed. Edinburgh: Elsevier
Saunders; 2012.p.774-789.
Paroxysmal Disorders. In: Piña-Garza J. Fenichel’s Clinical
Pediatric Neurology. 7th ed. Elsevier Saunders. 2013.p.1-46.
Menkes JH, Sarnat HB. Maria BL. Editors Child Neurology.
7th ed. Philadelphia: Lippincott Williams & Wilkins.
2006;p:857-942.
Zuberi SM, Symonds JD. Update on diagnosis and
management of childhood epilepsies. J Pediatr (Rio J).
2015;91:S67-77. doi: 10.1016/j.jped.2015.07.003.
Sakakihara Y. Treatment of West syndrome. Brain Dev-Jpn.
2011;33(3):202-206. doi: 10.1016/j.braindev.2010.12.004.
Lux AL. Latest American and European update on infantile
spasms. Curr Neurol Neurosci Rep. 2013;13(3):334.
Cohen-Sadan S, Kramer U, Ben-Zeev B, Lahat E, Sahar E,
Nevo Y, et al. Multi-center long-term follow-up of children
with idiopathic West syndrome: ACTH versus vigabatrin.
Eur J Neurol. 2009; 16:482–487.
Mohammed IN, MA Moneim, AA Rahman. The profile
of childhood epilepsy in Sudan. Khartoum Med J.
2010;3(2):444-447.
Kaushik JS, Patra B, Sharma S, Yadav D, Aneja S. Clinical
spectrum and treatment outcome of West Syndrome in
children from Northern India. Seizure. 2013;22(8):617-621.
doi: 10.1016/j.seizure.2013.04.014.
Pak J Med Sci

November - December 2018

16. Riikonen R. Epilepsy: Update to guidelines on treatment of
infantile spasms. Nat Rev Neurol. 2012;8(9):480-215
17. Karvelas G, Lortie A, Scantlebury MH, Duy PT, Cossette
P, Carmant L. A retrospective study on aetiology based
outcome of infantile spasms. Seizure. 2009;18(3):197-201.
doi: 10.1016/j.seizure.2008.09.006.
18. Hussain SA, Lay J, Cheng E, Weng J, Sankar R, Christine B,
et al. Recognition of infantile spasms is often delayed: The
ASSIST Study. J Pediatr. 2017;190:215-221. doi: 10.1016/j.
jpeds.2017.08.009.
19. Auvin S, Hartman AL, Desnous B, Moreau AC, Alberti C,
Delanoe C. Diagnosis delay in West syndrome: Misdiagnosis
and consequences. Eur J Pediatr. 2012;171:1695-1701.
20. Pandey S. Challenges in neurological practice in developing
countries. Indian J Public Health. 2012;56(3):227-230.
21. Ibrahim S, Gulab S, Ishaque S, Saleem T. Clinical profile
and treatment of infantile spasms using vigabatrin and
ACTH-a developing country perspective. BMC Pediatrics.
2010;10(1):1. doi: 10.1186/1471-2431-10.
22. Wirrell EC, Shellhaas RA, Joshi C, Keator C, Kumar
S, Mitchell WG, et al. How should children with West
syndrome be efficiently and accurately investigated? Results
from the National Infantile Spasms Consortium. Epilepsia.
2015;56(4):617-625. doi: 10.1111/epi.129512.
23. Keshave A, Yende-Zuma N, Mubaiwa L, Adhikari M. The
clinical profile and outcome of children with West syndrome
in KwaZulu-Natal Province, South Africa: A 10-year
retrospective review. S Afr J Child Health. 2017;11(3):135140. doi: 10.7196/SAJCH. 2017.v11i3.1300.
24. Go CY, Mackay MT, Weiss SK, Stephens D, AdamsWebber T, Ashwal S, et al. Evidence-based guide line
update: Medical treatment of infantile spasms. Report of
the Guideline Development Subcommittee of the American
Academy of Neurology and the Practice Committee of the
Child Neurology Society. Neurology. 2012;78:1974–1980.
doi: 10.1212/WNL.0b013e318259e2cf
25. Gaily E, Lommi M, Lapatto R, Lehesjoki AE. Incidence and
outcome of epilepsy syndromes with onset in the first year
of life: A retrospective population-based study. Epilepsia.
2016;57:1594-1601.

Author’s Contribution:
SK: Conceived ideas, data collection and prepared
manuscript.
SHI: Guided and edited manuscript.
SKJ: Did statistical analysis.
KNM: Reviewed for final approval of manuscript.
MA: Did write-up and literature search.

Authors:
1.
2.

Dr. Shazia Kulsoom, MBBS, FCPS.
Dr. Shahnaz H Ibrahim,
Professor of Pediatrics and Pediatric Neurologist,
3. Dr. Sidra Kaleem Jafri, MBBS, FCPS.
4. Dr. Khemchand N Moorani,
Professor of Pediatrics and Pediatric Nephrologist, NICH.
5. Dr. Misbah Anjum, MBBS, FCPS.
1-3: Department of Pediatrics and Child Health,
Aga Khan University Hospital,
Karachi, Pakistan.
4,5: Department of Pediatric Medicine Unit III,
National Institute of Child Health,
Karachi, Pakistan.

Vol. 34 No. 6

www.pjms.com.pk

1428

